Bout Me Healing
Boca Raton, Florida, 33496, United States
NCT Number: NCT07417579
Mindfulness and meditation based relapse prevention has been proposed as an adjunctive approach for individuals with substance use disorders (SUDs). This completed pilot observational case series describes outcomes from three de-identified participants who completed an eight-week mindfulness and meditation program designed to reduce stress, enhance coping skills, and support sustained recovery.
Participants demonstrated improvements in perceived stress and mindfulness following the intervention. Two participants experienced relapse within 10-12 months, while one participant maintained long-term sobriety. This small case series provides descriptive clinical insights and supports the feasibility of mindfulness-based interventions in real-world treatment settings.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Boca Raton, Florida, 33496, United States
This pilot observational case series evaluated an eight-week mindfulness and meditation-based relapse prevention program delivered to three de-identified adults with substance use disorders. The intervention included weekly guided mindfulness sessions, daily home practice, and group discussions focused on awareness of cravings, emotional regulation, and relapse prevention strategies.
Outcomes were assessed using self-reported perceived stress and mindfulness measures, along with qualitative clinical interviews and participant journals to monitor relapse behavior. All participants demonstrated improvements in perceived stress and mindfulness. Relapse occurred in two participants within one year, while one participant maintained long-term sobriety.
This study was exploratory and descriptive in nature, with a small sample size. Ethics review was not required as all participants were de-identified and the study was conducted as a clinical case series. Findings are intended to inform future research and larger-scale studies of mindfulness-based relapse prevention interventions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The mindfulness and meditation-based relapse prevention program consisted of an eight-week structured intervention delivered as part of routine clinical practice. Participants engaged in weekly guided mindfulness meditation sessions, daily individual home practice, and facilitated group discussions. The intervention focused on developing awareness of thoughts, emotions, cravings, and stress responses, with an emphasis on nonjudgmental observation and emotional regulation. Sessions included mindfulness exercises, breathing techniques, body awareness practices, and reflective discussion related to relapse prevention and coping strategies. The program was not designed as a randomized or controlled intervention and was implemented uniformly across participants.
Time frame: Baseline (pre-intervention) to end of the eight-week program
The primary outcome is the change in perceived stress and mindfulness levels in participants completing an eight-week mindfulness and meditation-based relapse prevention program. Stress was assessed using the Perceived Stress Scale and mindfulness using the Five Facet Mindfulness Questionnaire. Observations were collected through participant journals and clinical interviews, comparing baseline to post-intervention outcomes. This outcome reflects the feasibility and potential impact of mindfulness-based practices in supporting emotional regulation and coping strategies for individuals with substance use disorders.
Bout Me Healing
Industry
Observational Case Series of Mindfulness- and Meditation-Based Relapse Prevention for Substance Use Disorders (MBRP-SUD)
Acronym: MBRP-SUD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04162977
Adolescent Development, Behavior
Montreal, Quebec, Canada
View Trial DetailsNCT06856148
Chemically-Induced Disorders, Legislation
University Park, Pennsylvania, United States
View Trial DetailsNCT06738953
Affective Disorders, Anxiety Disorders
Potsdam, Brandenburg, Germany
View Trial DetailsNCT06439329
Chemically-Induced Disorders, Mental Disorders
New Haven, Connecticut, United States
View Trial Details